GSK2256098
Drug timelines are a Plus or Pro feature.
3 regulatory and trial events tracked for GSK2256098, covering 2017-06-14 to 2022-11-01. Get the full timeline:
Most recent: Clinical Trial Update: A Study of GSK2256098 and Trametinib in Advanced Pancreatic Cancer [Phase 2]